Publikationen, an denen er mitarbeitet DAVID LORA PABLOS (151)

2024

  1. Applied biostatistics in clinical trials for 15-year-old pupils

    Teaching Statistics, Vol. 46, Núm. 1, pp. 1-7

  2. Cook's balloon versus dinoprostone for Labour induction of term pregnancies with fetal GROWth restriction: Study protocol for a randomised controlled trial in tertiary maternity hospitals in Spain (COLIGROW study)

    BMJ Open, Vol. 14, Núm. 9

  3. Prediction of individual lifetime cardiovascular risk and potential treatment benefit: Development and recalibration of the LIFE-CVD2 model to four European risk regions

    European Journal of Preventive Cardiology, Vol. 31, Núm. 14, pp. 1690-1699

  4. Real-world study of pegylated interferon α-2a to treat mycosis fungoides/Sézary syndrome using time to next treatment as a measure of clinical benefit: an EORTC CLTG study

    British Journal of Dermatology, Vol. 191, Núm. 3, pp. 419-427

2023

  1. Characteristics of clinical trials of influenza and respiratory syncytial virus registered in ClinicalTrials.gov between 2014 and 2021

    Frontiers in Public Health, Vol. 11

  2. Evaluation of the effectiveness and safety of oral vancomycin versus placebo in the prevention of recurrence of Clostridioides difficile infection in patients under systemic antibiotic therapy: a phase III, randomised, double-blind clinical trial

    BMJ open, Vol. 13, Núm. 9, pp. e072121

  3. Extremely missing numerical data in Electronic Health Records for machine learning can be managed through simple imputation methods considering informative missingness: A comparative of solutions in a COVID-19 mortality case study

    Computer Methods and Programs in Biomedicine, Vol. 242

  4. How, when, and to what degree do people with alcohol dependence recover their psychological wellbeing and quality of life? The Madrid Recovery Project

    Frontiers in Psychiatry, Vol. 14

  5. Life expectancy associated with different ages at diagnosis of type 2 diabetes in high-income countries: 23 million person-years of observation

    The Lancet Diabetes and Endocrinology, Vol. 11, Núm. 10, pp. 731-742

  6. Mammographic density in the environs of multiple industrial sources

    Science of the Total Environment, Vol. 876

  7. No changes in hemostasis after COVID-19–heterologous vaccination schedule: A subanalysis of the phase 2 CombiVacS study

    Research and Practice in Thrombosis and Haemostasis, Vol. 7, Núm. 1

  8. Serum GDF-15 Levels Accurately Differentiate Patients with Primary Mitochondrial Myopathy, Manifesting with Exercise Intolerance and Fatigue, from Patients with Chronic Fatigue Syndrome

    Journal of Clinical Medicine, Vol. 12, Núm. 6

2022

  1. A predictive score at admission for respiratory failure among hospitalized patients with confirmed 2019 Coronavirus Disease: a simple tool for a complex problem

    Internal and Emergency Medicine, Vol. 17, Núm. 2, pp. 515-524

  2. Activity and safety of topical pimecrolimus in patients with early stage mycosis fungoides (PimTo-MF): a single-arm, multicentre, phase 2 trial

    The Lancet Haematology, Vol. 9, Núm. 6, pp. e425-e433

  3. Efficacy of continuous glucose monitoring on maternal and neonatal outcomes in gestational diabetes mellitus: a systematic review and meta-analysis of randomized clinical trials

    Diabetic Medicine, Vol. 39, Núm. 1

  4. Geographical and Temporal Variability of Ultra-Processed Food Consumption in the Spanish Population: Findings from the DRECE Study

    Nutrients, Vol. 14, Núm. 15

  5. Growth patterns of normo-nourished Afghan, Haitian and Congolese children aged 6–59 months: A comparative study

    American Journal of Human Biology, Vol. 34, Núm. 2

  6. Immunogenic dynamics and SARS-CoV-2 variant neutralisation of the heterologous ChAdOx1-S/BNT162b2 vaccination: Secondary analysis of the randomised CombiVacS study

    eClinicalMedicine, Vol. 50

  7. Metrics of progression and prognosis in untreated adults with thymidine kinase 2 deficiency: An observational study

    Neuromuscular Disorders, Vol. 32, Núm. 9, pp. 728-735

  8. Mild-to-Moderate Kidney Dysfunction and Cardiovascular Disease: Observational and Mendelian Randomization Analyses

    Circulation, Vol. 146, Núm. 20, pp. 1507-1517